文献速递癫痫认知障碍与痴呆

颞叶癫痫患者疾病进展模式的MRI衍生建模

MRI-Derived Modeling of Disease Progression Patterns in Patients With Temporal Lobe Epilepsy.
PubMed 文献 · Neurology · 2024-07-09

研究对82例颞叶癫痫患者和41名对照者的横断面MRI数据应用亚型与分期推断算法,识别出3种脑病理轨迹亚型,各亚型在起病年龄、热性惊厥、耐药、MRI阳性、海马硬化及Engel-I结局比例上存在差异,并与认知表现和药物反应预测相关。

要点

  • 基于横断面MRI识别出3种颞叶癫痫进展亚型,患者亚型与分期归属一致率>90%。
  • S1亚型早期起病、热性惊厥、耐药、MRI阳性、海马硬化和Engel-I结局比例最高,S2居中,S3最低。
  • 联合亚型与分期的分类器预测药物反应和Engel-I结局优于单用亚型或单用分期模型。

核心结论

  • 横断面MRI衍生模型可提供颞叶癫痫疾病演变的可靠预后标志物,疾病沿不同轨迹进展,各轨迹伴随不同的海马与全脑结构改变及认知和临床特征。

研究设计与样本

  • 研究纳入连续转诊至蒙特利尔神经病学研究所癫痫门诊、接受神经科医生评估的颞叶癫痫患者,均完成住院视频脑电图监测和3特斯拉多模态MRI(3D T1、液体衰减反转恢复及2D弥散加权MRI)。
  • 队列包括耐药性癫痫和药物反应性癫痫患者,神经心理评估包括韦氏成人智力量表-III和Leonard敲击任务。
  • 对照组为通过广告招募的无颞叶癫痫参与者,接受与患者相同的MRI采集。
  • 基于灰质形态和白质微结构的表面分析,采用亚型与分期推断算法估计脑病理亚型和分期,并将每例患者分配至相应亚型和分期。
  • 共研究82例颞叶癫痫患者(52例女性,平均年龄35±10岁;11例药物反应性)和41名对照参与者(23例男性,平均年龄32±8岁)。

主要发现

  • 识别出3种轨迹亚型:S1(n=35)以同侧海马萎缩和胶质增生为先导,随后出现白质损伤;S2(n=27)以双侧新皮质萎缩为特征,随后出现同侧海马萎缩和胶质增生;S3(n=20)以双侧边缘系统白质损伤为典型,随后出现双侧海马胶质增生。
  • 患者对其亚型和分期的归属一致率高(自举法一致率>90%)。
  • S1亚型中早期起病(效应量d=0.27 vs S2,d=0.73 vs S3)、热性惊厥(χ2=3.70)、耐药(χ2=2.94)、MRI阳性(χ2=8.42)、海马硬化(χ2=7.57)和Engel-I结局(χ2=1.51)的患者比例最高,所有比较pFDR<0.05;S2和S3比例分别居中与最低。
  • 与S3相比,S1言语智商和数字广度较低(d=0.65和d=0.50,pFDR<0.05),S2亦较低(d=0.76和d=1.09,pFDR<0.05)。
  • 与S2(T=2.14,pFDR=0.035)相比,S1和S3的序列运动敲击表现进行性下降(T=-3.38和T=-4.94,pFDR=0.027);S3数字广度进行性下降(T=-5.83,p=0.021)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Temporal lobe epilepsy (TLE) is assumed to follow a steady course that is similar across patients. To date, phenotypic and temporal diversities of TLE evolution remain unknown. In this study, we aimed at simultaneously characterizing these sources of variability based on cross-sectional data. METHODS: We studied consecutive patients with TLE referred for evaluation by neurologists to the Montreal Neurological Institute epilepsy clinic, who underwent in-patient video EEG monitoring and multimodal imaging at 3 Tesla, comprising 3D T1 and fluid-attenuated inversion recovery and 2D diffusion-weighted MRI. The cohort included patients with drug-resistant epilepsy and patients with drug-responsive epilepsy. The neuropsychological evaluation included Wechsler Adult Intelligence Scale-III and Leonard tapping task. The control group consisted of participants without TLE recruited through advertisement and who underwent the same MRI acquisition as patients. Based on surface-based analysis of key MRI markers of pathology (gray matter morphology and white matter microstructure), the Subtype and Stage Inference algorithm estimated subtypes and stages of brain pathology to which individual patients were assigned. The number of subtypes was determined by running the algorithm 100 times and estimating mean and SD of disease trajectories and the consistency of patients' assignments based on 1,000 bootstrap samples. Effect of normal aging was subtracted from patients. We examined associations with clinical and cognitive parameters and utility for individualized predictions. RESULTS: We studied 82 patients with TLE (52 female, mean age 35 ± 10 years; 11 drug-responsive) and 41 control participants (23 male, mean age 32 ± 8 years). Among 57 operated, 43/37/20 had Engel-I outcome/hippocampal sclerosis/hippocampal isolated gliosis, respectively. We identified 3 trajectory subtypes: S1 (n = 35), led by ipsilateral hippocampal atrophy and gliosis, followed by white-matter damage; S2 (n = 27), characterized by bilateral neocortical atrophy, followed by ipsilateral hippocampal atrophy and gliosis; and S3 (n = 20), typified by bilateral limbic white-matter damage, followed by bilateral hippocampal gliosis. Patients showed high assignability to their subtypes and stages (>90% bootstrap agreement). S1 had the highest proportions of patients with early disease onset (effect size d = 0.27 vs S2, d = 0.73 vs S3), febrile convulsions (χ2 = 3.70), drug resistance (χ2 = 2.94), a positive MRI (χ2 = 8.42), hippocampal sclerosis (χ2 = 7.57), and Engel-I outcome (χ2 = 1.51), pFDR < 0.05 across all comparisons. S2 and S3 exhibited the intermediate and lowest proportions, respectively. Verbal IQ and digit span were lower in S1 (d = 0.65 and d = 0.50, pFDR < 0.05) and S2 (d = 0.76 and d = 1.09, pFDR < 0.05), compared with S3. We observed progressive decline in sequential motor tapping in S1 and S3 (T = -3.38 and T = -4.94, pFDR = 0.027), compared with S2 (T = 2.14, pFDR = 0.035). S3 showed progressive decline in digit span (T = -5.83, p = 0.021). Supervised classifiers trained on subtype and stage outperformed subtype-only and stage-only models predicting drug response in 73% ± 1.0% (vs 70% ± 1.4% and 63% ± 1.3%) and 76% ± 1.6% for Engel-I outcome (vs 71% ± 0.8% and 72% ± 1.1%), pFDR < 0.05 across all comparisons. DISCUSSION: Cross-sectional MRI-derived models provide reliable prognostic markers of TLE disease evolution, which follows distinct trajectories, each associated with divergent patterns of hippocampal and whole-brain structural alterations, as well as cognitive and clinical profiles.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Lee HM, Fadaie F, Gill RS, et al. MRI-Derived Modeling of Disease Progression Patterns in Patients With Temporal Lobe Epilepsy. Neurology. 2024. PMID: 38981074. doi:10.1212/WNL.0000000000209524

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。